减压支撑面:随机评估2(PRESSURE 2):一项随机对照试验的研究方案
PRESSURE 2是一项多中心、开放标签、随机、双三角、成组序贯、平行组试验,拟纳入最多2954例有急性疾病证据的高风险患者,1:1随机接受高规格泡沫床垫或交替压力床垫,主要比较至治疗阶段结束后30天时新发2期及以上压力性损伤的时间。
要点
- PRESSURE 2比较高规格泡沫床垫与交替压力床垫预防压力性损伤的效果。
- 主要终点为至治疗阶段结束后30天新发2期及以上压力性损伤的时间。
- 试验采用双三角成组序贯设计,最多进行三次计划分析,无效界值为非约束性。
核心结论
- PRESSURE 2试验的双三角成组序贯设计可通过早期停止来证明床垫的优效性、劣效性或试验无效,从而提供高效设计。
- 该试验优化了比传统设计更早产生关于两种临床常用床垫有效性的稳健临床证据的潜力。
研究设计与样本
- PRESSURE 2是一项多中心、开放标签、随机、双三角、成组序贯、平行组试验。
- 拟随机最多2954例有急性疾病证据的高风险患者,按1:1接受高规格泡沫床垫或交替压力床垫,并联合电动可调床架。
- 试验最多进行三次计划分析,在事件驱动的连贯切点进行不等间隔审查,无效界值构建为非约束性,以便数据监测与伦理委员会可推翻提前停止的决定。
关键数值与推荐
- 主要目标为比较床垫在至治疗阶段结束后30天时新发2期及以上压力性损伤的时间方面的差异。
- 次要终点包括至新发1期和3期及以上压力性损伤的时间、既存2期压力性损伤的愈合时间、健康相关生活质量、成本效果、床垫更换发生率及安全性。
- 验证目标为确定压力性损伤生活质量-预防工具的反应性以及使用摄影进行盲法终点评估的可行性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pressure ulcers represent a major burden to patients, carers and the healthcare system, affecting approximately 1 in 17 hospital and 1 in 20 community patients. They impact greatly on an individual's functional status and health-related quality of life. The mainstay of pressure ulcer prevention practice is the provision of pressure redistribution support surfaces and patient repositioning. The aim of the PRESSURE 2 study is to compare the two main mattress types utilised within the NHS: high-specification foam and alternating pressure mattresses, in the prevention of pressure ulcers. METHODS/DESIGN: PRESSURE 2 is a multicentre, open-label, randomised, double triangular, group sequential, parallel group trial. A maximum of 2954 'high-risk' patients with evidence of acute illness will be randomised on a 1:1 basis to receive either a high-specification foam mattress or alternating-pressure mattress in conjunction with an electric profiling bed frame. The primary objective of the trial is to compare mattresses in terms of the time to developing a new Category 2 or above pressure ulcer by 30 days post end of treatment phase. Secondary endpoints include time to developing new Category 1 and 3 or above pressure ulcers, time to healing of pre-existing Category 2 pressure ulcers, health-related quality of life, cost-effectiveness, incidence of mattress change and safety. Validation objectives are to determine the responsiveness of the Pressure Ulcer Quality of Life-Prevention instrument and the feasibility of having a blinded endpoint assessment using photography. The trial will have a maximum of three planned analyses with unequally spaced reviews at event-driven coherent cut-points. The futility boundaries are constructed as non-binding to allow a decision for stopping early to be overruled by the Data Monitoring and Ethics Committee. DISCUSSION: The double triangular, group sequential design of the PRESSURE 2 trial will provide an efficient design through the possibility of early stopping for demonstrating either superiority, inferiority of mattresses or futility of the trial. The trial optimises the potential for producing robust clinical evidence on the effectiveness of two commonly used mattresses in clinical practice earlier than in a conventional design. TRIAL REGISTRATION: ISRCTN01151335 . Registered on 14 May 2013. Protocol version: 5.0, dated 25 September 2015 Trial sponsor: Clare Skinner, Faculty Head of Research Support, University of Leeds, Leeds, LS2 9JT; 0113 343 4897; C.E.Skinner@leeds.ac.uk.
引用
- Brown S, Smith IL, Brown JM, et al. Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trial. Trials. 2016. PMID: 27993145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。